TRI-, TETRA-, and penta-peptides having antiangiogenic activity

Details TRI-, TETRA-, and penta-peptides having antiangiogenic activity TRI-, TETRA-, and penta-peptides having antiangiogenic activity

2006-05-02

2006-05-02

Campell, Bruce R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S016700, C530S329000

Reexamination Certificate

active

07037897

ABSTRACT:
Compounds of formula (SEQ ID NO:1), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.

REFERENCES:
patent: 2003/0105022 (2003-06-01), Haviv et al.
patent: 05-306295 (1992-04-01), None
patent: 05-306295 (1993-11-01), None
patent: 99/61476 (1999-12-01), None
patent: 01/38347 (2001-05-01), None
patent: 01/38397 (2001-05-01), None

Affiliated with

Also associated with

Rating

TRI-, TETRA-, and penta-peptides having antiangiogenic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with TRI-, TETRA-, and penta-peptides having antiangiogenic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and TRI-, TETRA-, and penta-peptides having antiangiogenic activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3585875